Temozolomide Bests Nivolumab in Glioblastoma With Unmethylated MGMT Promoter
Overall and progression-free survival were superior with temozolomide.
Brain Cancer
MRI Radiomics Prediction Model for Patients With Glioma Shows Stability
Researchers sought to develop and validate an MRI radiomics prediction model through a machine learning-based method to predict the survival of patients with glioma.
Dabrafenib Plus Trametinib Effective for Gliomas With BRAF V600E Mutations
Researchers sought to evaluate the activity and safety of dabrafenib plus trametinib in adult patients with recurrent or progressive BRAF V600E -mutation–positive high-grade and low-grade glioma.
Cabozantinib Shows Promise for Renal Cell Carcinoma With Brain Metastases
The researchers sought to assess the safety and efficacy of cabozantinib to treat brain metastases in patients with metastatic renal cell carcinoma.
2008 to 2017 Saw Decrease in Malignant Brain Tumor Incidence
From 2008 to 2017, the incidence of malignant brain tumors decreased for all ages combined, but increased among children and adolescents.
Combination Immunotherapy Effective for Patients With Melanoma and Asymptomatic Brain Metastases
The combination of nivolumab with ipilimumab is an effective treatment option for patients with advanced melanoma with asymptomatic brain metastases
Occult Brain Metastasis Detected in Patients With Advanced Renal Cancer
Occult brain metastasis is identified in about 4 percent of patients with metastatic renal cell carcinoma (mRCC).
Socioeconomics Tied to Cognitive Function in Survivors of Childhood Brain Tumors
Researchers hope their findings could lead to targeted interventions to improve cognitive outcomes in pediatric brain tumor survivors from families with low socioeconomic status.
Laser-Based Imaging and Artificial Intelligence May Diagnose Brain Tumors in OR
A novel workflow that combines advanced optical imaging with an artificial intelligence algorithm may accurately diagnose brain tumors in real time in the operating room.
Non-melanoma Skin Cancers Are Less Likely to be Treated in Elderly Patients
Unlike previous studies, the researchers found that in their practice, no-treatment rates between elderly and nonelderly patients with biopsy-proven NMSCs were significantly different.
- Loading...
Loading...
Next post in General Neurology
Loading... 
Loading...